(Q57220173)
Statements
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients (English)
Laurence Zitvogel
Cedric Menard
Pierre Emmanuel Puig
Sylvain Ladoire
Stephan Roux
Axel Le Cesne
Bruno Chauffert
8 September 2006